4/10
06:08 am
dnth
Dianthus Therapeutics (DNTH) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Dianthus Therapeutics (DNTH) was upgraded by Wolfe Research to "strong-buy".
4/10
06:08 am
dnth
Dianthus Therapeutics (DNTH) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Dianthus Therapeutics (DNTH) was upgraded by Wolfe Research to "strong-buy".
4/9
12:16 pm
dnth
Rating for DNTH
Low
Report
Rating for DNTH
4/9
12:16 pm
dnth
Rating for DNTH
Low
Report
Rating for DNTH
4/9
09:00 am
dnth
Dianthus Therapeutics (DNTH) is now covered by Wolfe Research. They set an "outperform" rating and a $98.00 price target on the stock.
Medium
Report
Dianthus Therapeutics (DNTH) is now covered by Wolfe Research. They set an "outperform" rating and a $98.00 price target on the stock.
4/9
09:00 am
dnth
Dianthus Therapeutics (DNTH) is now covered by Wolfe Research. They set an "outperform" rating and a $98.00 price target on the stock.
Medium
Report
Dianthus Therapeutics (DNTH) is now covered by Wolfe Research. They set an "outperform" rating and a $98.00 price target on the stock.
4/8
04:38 pm
dnth
Dianthus initiated with an Outperform at Wolfe Research
Medium
Report
Dianthus initiated with an Outperform at Wolfe Research
4/8
04:38 pm
dnth
Dianthus initiated with an Outperform at Wolfe Research
Medium
Report
Dianthus initiated with an Outperform at Wolfe Research
3/19
09:16 am
dnth
Dianthus Therapeutics (DNTH) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $135.00 price target on the stock.
Low
Report
Dianthus Therapeutics (DNTH) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $135.00 price target on the stock.
3/19
09:02 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
3/19
09:02 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
3/19
05:56 am
dnth
Dianthus initiated with an Overweight at Wells Fargo
Low
Report
Dianthus initiated with an Overweight at Wells Fargo
3/19
05:56 am
dnth
Dianthus initiated with an Overweight at Wells Fargo
Low
Report
Dianthus initiated with an Overweight at Wells Fargo
3/16
12:08 pm
dnth
Dianthus Therapeutics (DNTH) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Dianthus Therapeutics (DNTH) had its "outperform" rating reaffirmed by William Blair.
3/16
12:08 pm
dnth
Dianthus Therapeutics (DNTH) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Dianthus Therapeutics (DNTH) had its "outperform" rating reaffirmed by William Blair.
3/12
11:00 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
3/12
11:00 am
dnth
Rating for DNTH
Low
Report
Rating for DNTH
3/10
08:35 am
dnth
Dianthus Therapeutics (DNTH) was upgraded by Raymond James Financial, Inc. from "outperform" to "strong-buy". They now have a $123.00 price target on the stock, up from $63.00.
High
Report
Dianthus Therapeutics (DNTH) was upgraded by Raymond James Financial, Inc. from "outperform" to "strong-buy". They now have a $123.00 price target on the stock, up from $63.00.
3/10
08:23 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
3/10
08:23 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
3/10
08:08 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
3/10
08:08 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
3/10
06:56 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
3/10
06:56 am
dnth
Rating for DNTH
High
Report
Rating for DNTH
3/10
05:21 am
dnth
Dianthus upgraded to Strong Buy from Outperform at Raymond James
High
Report
Dianthus upgraded to Strong Buy from Outperform at Raymond James